Elevating the Patient Voice in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trials

J Clin Oncol. 2022 Mar 10;40(8):807-810. doi: 10.1200/JCO.21.02504. Epub 2022 Jan 6.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Androstenes
  • Docetaxel / therapeutic use
  • Hormones / therapeutic use
  • Humans
  • Male
  • Prostatic Neoplasms* / drug therapy
  • Prostatic Neoplasms* / pathology
  • Quality of Life*

Substances

  • Androstenes
  • Hormones
  • Docetaxel
  • abiraterone